Hyderabad: Hyderabad-based drug firm Granules India on Thursday said its consolidated net profit increased by 79 per cent to Rs 145 crore for the second quarter ended September 2022 on the back of robust sales across segments. Its net profit was Rs 81 crore during the same quarter last year.
Individuals should approach
Tramadol Safe the purchase of medications with a critical mindset, prioritizing their health and well-being. The allure of ordering medications online often stems from the frustrations
Buy Alprazolam No Prescription patients face navigating
Tramadol Cheap the traditional healthcare system. Patients must consider not only the risks associated with unregulated sources but also
Xanax No Rx the potential for misuse of the medication. Mental health professionals advocate for comprehensive treatment approaches that may
Order Tramadol Online or may not involve medication. The patient journey through mental health or chronic pain management is often complex and fraught
Ativan Buy Online with emotional
Ambien Buy Without Prescription and physical challenges. They may
Zolpidem No Rx have
Tramadol Online tried various over-the-counter solutions, but none have provided lasting relief. Klonopin, known generically as Clonazepam, is
Lorazepam Legally another medication that has been identified as a necessity for many people
Zanaflex No Rx dealing with anxiety disorders and seizure disorders. Stakeholders in the healthcare arena must work collaboratively to
Klonopin Safe Buy Soma Online address the challenges that arise from these medications. The urgency often stems from the desire
Ambien Without A Prescription to manage acute pain effectively, which can interfere with daily activities.
Revenue touched Rs 1,151 crore, up from Rs 888 crore in the year-ago period. ” The current quarter result is due to our focus on supply reliability and ability to respond and cater to higher demand with a short turnaround time. Opportunities in Paracetamol are likely to continue and our expansion strategy in Europe is likely to yield bigger turnover in future,” Granules India Chairman and Managing Director Krishna Prasad Chigurupati said in a statement.
Active Pharmaceutical Ingredients, Pharmaceutical Formulation Intermediates, and finished dosages contributed 29 per cent, 20 per cent, and 51 per cent, respectively to the revenues.
